Cargando…
Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons – the APROVE-trial
BACKGROUND: The prognosis for patients with cervical or endometrial cancer has improved over the last decades. Thus, reducing therapy-related toxicity and impact on quality of life have become more and more important. With the development of new radiotherapy techniques like IMRT (Intensity-modulated...
Autores principales: | Arians, N., Lindel, K., Krisam, J., Herfarth, K., Krug, D., Akbaba, S., Oelmann-Avendano, J., Debus, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704365/ https://www.ncbi.nlm.nih.gov/pubmed/29179751 http://dx.doi.org/10.1186/s13014-017-0926-5 |
Ejemplares similares
-
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial
por: Meixner, Eva, et al.
Publicado: (2023) -
Percutaneous Parametrial Dose Escalation in Women with Advanced Cervical Cancer: Feasibility and Efficacy in Relation To Long-term Quality of Life
por: Akbaba, Sati, et al.
Publicado: (2018) -
Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) – a prospective, randomized, 2-armed phase-II-trial
por: Arians, Nathalie, et al.
Publicado: (2020) -
CERN's biggest contributor aproves new laboratory
por: CERN Press Office. Geneva
Publicado: (1968) -
Second breast conserving therapy after ipsilateral breast tumor recurrence – a 10-year experience of re-irradiation
por: Forster, Tobias, et al.
Publicado: (2019)